Overexpression of PDK1 in cancer cells inhibits the PDC-catalyzed tricarboxylic acid cycle (TCA cycle), resulting in the inability of aerobic oxidation, which may cause cancer cells to prefer other nutrients as their new energy source or other metabolic pathways to obtain large amounts of energy substances. Here, PDC is linked to cancer.